Review on the protective mechanism of astragaloside IV against cardiovascular diseases
Frontiers in Pharmacology · 11.05.2023 · 14
DOI: 10.3389/fphar.2023.1187910 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 11.05.2023. Verfasst von Chunkun Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cardiovascular disease is a global health problem. Astragaloside IV (AS-IV) is a saponin compound extracted from the roots of the Chinese herb Astragalus . Over the past few decades, AS-IV has been shown to possess various pharmacological properties. It can protect the myocardium through antioxidative stress, anti-inflammatory effects, regulation of calcium homeostasis, improvement of myocardial energy metabolism, anti-apoptosis, anti-cardiomyocyte hypertrophy, anti-myocardial fibrosis, regulation of myocardial autophagy, and improvement of myocardial microcirculation. AS-IV exerts protective effects on blood vessels. For example, it can protect vascular endothelial cells through antioxidative stress and anti-inflammatory pathways, relax blood vessels, stabilize atherosclerotic plaques, and inhibit the proliferation and migration of vascular smooth muscle cells. Thus, the bioavailability of AS-IV is low. Toxicology indicates that AS-IV is safe, but should be used cautiously in pregnant women. In this paper, we review the mechanisms of AS-IV prevention and treatment of cardiovascular diseases in recent years to provide a reference for future research and drug development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Emergency, Weifang Hospital of Traditional Chinese Medicine, Weifang, China.
Zitieren
APA
Yang, C., Pan, Q., Ji, K., Tian, Z., Zhou, H., Li, S., Luo, C., & Li, J. (2023). Review on the protective mechanism of astragaloside IV against cardiovascular diseases. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1187910
Vancouver
Yang C, Pan Q, Ji K, Tian Z, Zhou H, Li S, et al. Review on the protective mechanism of astragaloside IV against cardiovascular diseases. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1187910
BibTeX
@article{Yang2023,
author = {Yang, Chunkun and Pan, Qingquan and Ji, Kui and Tian, Zhuang and Zhou, Hongyuan and Li, Shuanghong and Luo, Chuanchao and Li, Jun},
title = {Review on the protective mechanism of astragaloside IV against cardiovascular diseases},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1187910}
}
EUVIMED